Xilloc Medical BV â€œWe are committed to making absolutely individual piecesâ€?
Xilloc Medical B.V. is dedicated to the accurate and reliable production of highly specialised Patient Specific Implants (PSI) to replace parts of the human skeleton. History: In 2003, the departments of Oral and Maxillofacial Surgery and Plastic Surgery indicated a need for a product that could repair major skull defects during surgery; a product that would not only fit perfectly, but would also deliver an aesthetically pleasing result. Until now, repairing major skull defects was an extremely complicated undertaking: the implant had to be manually sculpted, cast and placed, resulting in long and complex operations with an aesthetically poor result. Multiple follow-up surgeries were often required. In collaboration with the departments of Oral and Maxillofacial Surgery and Plastic Surgery, IDEE (the engineering firm for high-tech medical instruments at Maastricht University) developed a technique that allowed for the preoperative design and production of PSI’s using CT scans of the patient. The Maastricht University Medical Centre (MUMC+) then spent the next seven years designing, manufacturing and using these implants. PSI’s turned out to be a great success. To meet market demands outside MUMC+, Maastricht Instruments B.V. launched a spin-off company on 24 August 2011 called Xilloc Medical B.V. The company is committed to revolutionising the implant industry. With Xilloc’s comprehensive range of implant solutions, patients will need fewer surgeries to get an aesthetically superior and safer result and hospitals and insurance companies will save a significant amount of money. Key players in the field of oral and maxillofacial surgical reconstruction have indicated that patient-specific implants will herald a real revolution. The ambitious entrepreneur Maikel Beerens is working on establishing a solid foundation in Europe in order to expand Xilloc Medical worldwide. The company recently launched a new innovation by designing, printing and delivering the world’s first patient-specific titanium implant and using it to successfully replace a patient’s jawbone. This procedure allowed the patient to retain vital functions such as speech, breathing, chewing, nerve sensation and aesthetics, which would have certainly been lost using conventional methods. Life science activities During the start-up phase, the focus was on generating awareness and building a solid foundation in Europe by using 3D printing technology to create PSI’s. This was a world first, mainly because the output of a CT scanner could not match the input of a 3D printer. Xilloc Medical solved this problem and made 3D printed PSI’s widely available. In the long term, Xilloc Medical plans on expanding to other patient-specific products.
As Xilloc Medical is housed in the incubator of the BioPartner Centre Maastricht, it can create job opportunities while retaining knowledge and competencies. Xilloc Medical contributes to the development of the regional life science sector by branding, binding and inspiring knowledge workers, adapting education to the labour market, developing ambitions, conducting research and attracting and stimulating the business community. The R&D, in collaboration with MUMC+, will continue to exist, thereby generating more space for similar innovations in the future. Xilloc Medical B.V. Oxfordlaan 70, 6229 EV Maastricht P.O. Box 1036, 6201 BA Maastricht W: www.xilloc.com E: email@example.com Contact person: Maikel Beerens, CEO T: +31 (0)43 3881881 M: +31 (0)6 44670942 E: firstname.lastname@example.org
In Randwijck, between the buildings of Maastricht University, Maastricht University Medical Centre + and MECC, develops one of the main cent...